PMID: 3670937Aug 1, 1987Paper

In situ management of confirmed central venous catheter-related bacteremia

The Pediatric Infectious Disease Journal
P M FlynnF F Barrett

Abstract

Thirty-one patients with suspected central venous catheter-related bacteremia were evaluated with comparative quantitative cultures of central venous and peripheral blood specimens. Using criteria developed from studies in bacteremic animals, 19 patients were confirmed to have catheter-related bacteremia. Antibiotic therapy was administered through the catheter (in situ therapy) in 17 of those patients to evaluate the feasibility of treating patients with true central venous catheter-related bacteremias without catheter removal. Bacteremia was successfully eradicated in 11 of 17 patients (65%), allowing 7 patients to retain their catheter a median of 157 days. This study validates the use of comparative quantitative blood cultures in the diagnosis of catheter-related bacteremia and indicates that in situ therapy is a rational alternative to catheter removal in patients with catheter-related bacteremia.

Citations

Feb 1, 1989·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S T FanK F Lau
Sep 1, 1989·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·P J Collignon, R Munro
Apr 1, 1995·Irish Journal of Medical Science·A McCarthyA O'Meara
Sep 29, 1999·Cardiovascular and Interventional Radiology·J Namyslowski, N H Patel
Sep 21, 2004·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Fabio PaglialongaNicola Principi
Dec 1, 1995·American Journal of Surgery·E D Whitman, A M Boatman
Aug 1, 1995·Seminars in Oncology Nursing·K A Rumsey, D K Richardson
Mar 1, 1996·Nutrition·K A Adal, B M Farr
Oct 19, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M C DouardB Eurin
Dec 12, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J L ShenepK S Slobod
Apr 24, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A H GaurJ L Shenep
May 22, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P LonguetC Leport
Apr 10, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Christopher J Crnich, Dennis G Maki
May 1, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Christopher J Crnich, Dennis G Maki
Aug 9, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Aditya H GaurRandall T Hayden
Jul 14, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Nasia Safdar, Dennis G Maki
May 20, 2000·The Pediatric Infectious Disease Journal·T G Boyce
Oct 1, 1996·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·H DegaB Dupont
May 6, 2004·Journal of Pediatric Hematology/oncology·Poyyapakkam R SrivathsLakshmi Venkateswaran
Jun 12, 2003·The Pediatric Infectious Disease Journal·Aditya H GaurRandall T Hayden
Jul 13, 2004·The Pediatric Infectious Disease Journal·Jeremy A FranklinPatricia M Flynn
Apr 29, 2005·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Rogier C J de JongeReinoud J B J Gemke
Apr 19, 2011·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Kevin M Valentine
Nov 1, 1989·Antimicrobial Agents and Chemotherapy·P Yagupsky, M A Menegus
Apr 17, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L A MermelUNKNOWN Society for Healthcare Epidemiology of America
Dec 1, 1998·International Journal of Antimicrobial Agents·C Yip, C Rotstein
Aug 31, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H C Traunecker, B J Morland
Jun 6, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Leonard A MermelDavid K Warren
Sep 30, 2003·Journal of Vascular and Interventional Radiology : JVIR·James E SilberzweigUNKNOWN Society of Interventional Radiology Technology Assessment Committee
Apr 6, 2004·Journal of Vascular and Interventional Radiology : JVIR·Keri Hall, Barry Farr
Jul 1, 1997·Journal of Vascular and Interventional Radiology : JVIR·K R Simpson
Jun 11, 2015·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Julie M FlynnNicole C Gavin
Feb 1, 1995·American Journal of Infection Control·M A ClemenceB M Farr
Oct 10, 1998·Journal of Pediatric Surgery·M E FallatL J Goldsmith
Jun 1, 1996·American Journal of Infection Control·G R JonesR P Dunaway
Oct 1, 1992·The Journal of Hospital Infection·J S RaoF Breatnach
Jul 1, 1993·Journal of Pediatric Surgery·V BansalV Kanchanapoom
May 1, 1992·The American Journal of Emergency Medicine·J Gryn, A Sacchetti

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Epigenetics Insights from Twin Studies

Find the latest research on epigenetics and twin studies here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Myocardial Stunning

Myocardial stunning is a mechanical dysfunction that persists after reperfusion of previously ischemic tissue in the absence of irreversible damage including myocardial necrosis. Here is the latest research.